| Serial Number | 90981257 |
| Word Mark | PARACHUTE |
| Filing Date | Friday, November 13, 2020 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, January 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 21, 2025 |
| Goods and Services | Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma for transplant purposes, and for use by others in scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals; Treatment of materials, namely, treatment of blood and blood plasma for transplant purposes, and for use by others in scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals |
| Description of Mark | The mark consists of the depiction of a stylized parachute design depicted in 3 parts, each depicted in a different shade of green, and the word "PARACHUTE" depicted in stylized lower case letters in the color green. |
| Goods and Services | Transport, distribution in the nature of delivery, and storage of blood plasma |
| Indication of Colors claimed | The color(s) green is/are claimed as a feature of the mark. |
| Goods and Services | Promoting the donation of blood and volunteer services and financial resources in the field of blood and human blood plasma donations by means of arranging and conducting incentive reward programs and compensation programs |
| Goods and Services | Medical laboratory services, namely, testing and screening of human blood plasma for scientific research and development purposes; Medical laboratory services regarding human blood plasma; scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals by means of processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; scientific research, and the research and development of medicine, therapeutics, and pharmaceuticals by means of treatment of blood and blood plasma |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 14, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 14, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 14, 2021 |
| Primary Code | 039 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 14, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Source Donor Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10153 |
| Party Name | Source Donor Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10153 |
| Event Date | Event Description |
| Tuesday, November 17, 2020 | NEW APPLICATION ENTERED |
| Thursday, January 14, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 15, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, April 22, 2021 | ASSIGNED TO EXAMINER |
| Friday, April 30, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, April 30, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 1, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 1, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 2, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 30, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, November 8, 2021 | SUSPENSION LETTER WRITTEN |
| Monday, November 8, 2021 | LETTER OF SUSPENSION E-MAILED |
| Monday, November 8, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, May 9, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, November 7, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, May 8, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, May 10, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, November 7, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, December 7, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, December 7, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 7, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 6, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, March 6, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, June 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 10, 2024 | LETTER OF SUSPENSION E-MAILED |
| Monday, June 10, 2024 | SUSPENSION LETTER WRITTEN |
| Monday, June 10, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, September 9, 2024 | DIVISIONAL REQUEST RECEIVED |
| Monday, September 9, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, September 16, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, September 19, 2024 | DIVISIONAL PROCESSING COMPLETE |
| Thursday, September 19, 2024 | ASSIGNED TO LIE |
| Friday, September 20, 2024 | FINAL REFUSAL WRITTEN |
| Friday, September 20, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, September 20, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, December 19, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, December 19, 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Thursday, December 19, 2024 | EX PARTE APPEAL-INSTITUTED |
| Friday, December 20, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 20, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 31, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 31, 2024 | EXPARTE APPEAL TERMINATED |
| Wednesday, January 15, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 21, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 21, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, December 19, 2024 | EXPARTE APPEAL RECEIVED AT TTAB |